Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Nov 22, 2021
- Accession no.
- 0001209191-21-066004
- Filed
- Nov 22, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $50.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Common Stock | PPurchaseAcquired | +409 | $35.07 | +$14,343.63 | 421,407 | Indirect | |
| Nov 18, 2021 | Common Stock | PPurchaseAcquired | +1,021 | $35.10 | +$35,837.1 | 422,428 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.